Gadoterate Meglumine Injection shortage
To Be Discontinued 8 presentations · 1 manufacturers · first FDA posting 2026-05-21 · last update 2026-06-30
Manufacturers: Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted 06/30/2026 Updated 06/30/2026 Discontinued 06/30/2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 05/21/2026 Updated 05/21/2026 Discontinued 05/21/2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted 06/30/2026 Updated 06/30/2026 Discontinued 06/30/2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 05/21/2026 Updated 05/21/2026 Discontinued 05/21/2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted 06/30/2026 Updated 06/30/2026 Discontinued 06/30/2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 05/21/2026 Updated 05/21/2026 Discontinued 05/21/2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted 06/30/2026 Updated 06/30/2026 Discontinued 06/30/2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 05/21/2026 Updated 05/21/2026 Discontinued 05/21/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)